Equities

Fermentalg SA

Fermentalg SA

Actions
Basic MaterialsChemicals
  • Price (EUR)0.547
  • Today's Change-0.018 / -3.19%
  • Shares traded232.25k
  • 1 Year change-37.13%
  • Beta1.2652
Data delayed at least 15 minutes, as of May 03 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Fermentalg SA is a France-based industrial biotechnology company. It specializes in the development of a technology which is used to produce molecules of interest and bypasses conventional methods using petrochemicals and also industrial fish farming. The Company offers a solution to the gradual depletion of two key resources: wild fish and petroleum. The Company's technology allows it to target a range of markets, such as human nutrition, animal feed, green chemicals, cosmetics and biofuels.

  • Revenue in EUR (TTM)4.06m
  • Net income in EUR-14.15m
  • Incorporated2009
  • Employees57.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Valerio Therapeutics SA1.44m-19.74m16.79m39.00--0.7233--11.64-0.1811-0.18110.01340.15040.0287--0.702457,720.00-39.19-25.87-51.38-30.6566.0489.79-1,367.57-381.62---586.700.2913---64.48-31.41-229.49--49.66--
Nfl Biosciences SAS0.00-3.48m17.21m3.00--4.37-----0.5396-0.53960.000.40970.00----0.00-80.79---125.59--------------0.0228-------149.78------
Phaxiam Therapeutics SA1.33m-23.49m17.47m51.00--0.6819--13.17-5.56-5.560.31394.220.0273--14.8226,000.00-48.37-50.69-66.94-66.25-----1,771.42-1,009.09---70.210.3412---80.05-21.50-10,201.75---56.68--
SMAIO SA7.62m1.06m17.88m37.0016.791.657.512.350.20380.20381.462.070.56240.187117.23206,027.607.81-7.8710.24-19.7696.9596.0413.89-22.482.5411.070.1991--212.18114.99-62.80------
NicOx SA3.57m-17.36m19.11m11.00--0.4163--5.35-0.3721-0.37210.07530.91280.0394--1.83324,909.10-19.13-19.22-21.35-20.78-----485.70-370.14----0.3172---54.787.2536.57---13.35--
Advicenne SA2.37m-10.39m20.31m25.00------8.58-1.03-1.030.2342-1.400.19386.101.9494,680.00-85.09-46.00-178.65-61.82-204.18-441.10-438.99-597.560.8356-6.224.33---12.3233.267.70--26.86--
Oncodesign Precision Medicine Opm SA1.07m-8.09m26.10m22.00--6.47--24.35-0.4863-0.48630.06450.22190.0613--1.3948,735.00-46.23---63.87--130.48---754.61------0.7052---86.57---3,399.73------
Groupe Berkem SA-100.00bn-100.00bn27.36m234.00--0.8684----------1.77------------------------0.8681--0.5091--11.98---231.35------
Predilife SA317.79k-4.22m28.65m19.00------90.14-1.14-1.140.0858-1.060.0695--2.0517,030.55-92.43-89.36-129.39-123.8197.2583.94-1,329.21-1,901.22---6.232.20--10.1179.85-15.58---18.51--
Fermentalg SA4.06m-14.15m29.57m57.00--0.7583--7.29-0.3233-0.32330.09320.72130.07530.5333.35---24.63-21.94-26.79-24.7113.2114.73-327.08-248.953.53-63.300.3323---46.9475.18-43.29---11.01--
Poxel SA1.55m-44.24m30.05m30.00------19.44-1.44-1.440.0507-1.220.0597--5.4230,920.00-170.71-31.97-432.50-55.940.1294---2,861.58-101.47---4.0811.28---94.97-33.77-32.13---8.49--
Gensight Biologics SA1.27m-26.22m30.96m16.00------24.43-0.5427-0.54270.0269-0.47260.0723--2,534.0079,187.50-149.52-79.44---144.54-----2,069.53-1,036.27---------50.93--5.09---58.28--
Global Bioenergies SA3.25m-8.66m34.65m46.00--3.33--10.66-0.4797-0.47970.18020.57430.16325.2165.6270,638.05-43.47-43.66-64.54-82.47-153.20-948.35-266.41-1,331.363.54--0.2626--365.8336.2527.78---19.49--
Abionyx Pharma SA4.75m-3.90m34.73m63.00--6.29--7.31-0.1382-0.13820.16830.170.296828.494.18---24.39---38.01--11.22---82.19--0.9785-3,882.000.4732--------------
genOway SA18.63m1.59m38.58m124.0022.932.269.622.070.18140.18142.121.840.58130.38812.50142,180.804.98-0.56156.72-0.805897.6193.728.56-1.122.1017.420.3344--21.6411.57341.09-16.63-18.02--
Biosynex SA93.05m-13.79m43.18m560.00------0.4641-1.94-1.94----------248,141.30--25.60--33.9025.2251.82-13.1520.26---4.45--14.72-48.6145.12-84.99118.26----
Data as of May 03 2024. Currency figures normalised to Fermentalg SA's reporting currency: Euro EUR

Institutional shareholders

8.85%Per cent of shares held by top holders
HolderShares% Held
Moneta Asset Management SASas of 27 Oct 20232.39m5.79%
OFI Invest Asset Management SAas of 31 Aug 2023400.00k0.97%
AXA Investment Managers (Paris) SAas of 28 Mar 2024315.00k0.76%
HSBC Global Asset Management (France) SAas of 29 Feb 2024243.39k0.59%
FPM Frankfurt Performance Management AGas of 29 Feb 2024170.00k0.41%
Chaussier Gestion SAas of 28 Mar 202470.00k0.17%
Gestys SAas of 26 Jan 202435.00k0.09%
Friedland Gestion SASas of 29 Dec 202319.90k0.05%
BlackRock Investment Management (UK) Ltd.as of 31 Jan 20226.94k0.02%
Turgot Asset Management SASas of 29 Dec 20231.67k0.00%
More ▼
Data from 29 Dec 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.